Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 549Carcinoma, Non-Small-Cell Lung 506Prostatic Neoplasms 335Colorectal Neoplasms 268Multiple Myeloma 267Neoplasms 259Leukemia, Myeloid, Acute 218Squamous Cell Carcinoma of Head and Neck 213Lung Neoplasms 206Neoplasm Metastasis 204Carcinoma, Hepatocellular 197Triple Negative Breast Neoplasms 172Melanoma 172Pancreatic Neoplasms 171Recurrence 153Ovarian Neoplasms 151Lymphoma 140Sarcoma 132Glioblastoma 132Brain Neoplasms 132Head and Neck Neoplasms 126Carcinoma, Renal Cell 126Leukemia, Lymphocytic, Chronic, B-Cell 125Stomach Neoplasms 123Lymphoma, Large B-Cell, Diffuse 123Rectal Neoplasms 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 104Uterine Cervical Neoplasms 101Urinary Bladder Neoplasms 101Myelodysplastic Syndromes 101

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Amyotrophic Lateral Sclerosis × 1 year × Clear all
NCT07002034 2026-06-03

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Reunion Neuroscience Inc

Phase 2 Recruiting
100 enrolled

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡